Hernández, Rodolfode Silva, Nipun LakshithaHudson, JemmaCruickshank, MoiraQuinton, RichardManson, PaulDhillo, Waljit SBhattacharya, SiladityaBrazzelli, MiriamJayasena, Channa N2024-06-192024-06-192024-03Hernández, R, de Silva, N L, Hudson, J, Cruickshank, M, Quinton, R, Manson, P, Dhillo, W S, Bhattacharya, S, Brazzelli, M & Jayasena, C N 2024, 'Cost-effectiveness of testosterone treatment utilising individual patient data from randomised controlled trials in men with low testosterone levels', Andrology, vol. 12, no. 3, pp. 477-486. https://doi.org/10.1111/andr.135970196-3635ORCID: /0000-0002-5182-884X/work/151301693ORCID: /0000-0002-4588-356X/work/159509796ORCID: /0000-0003-2619-8230/work/162727158https://hdl.handle.net/2164/23653ACKNOWLEDGEMENTS Professor Graham Scotland (Health Services Research Unit and Health Economics Research Unit, University of Aberdeen, UK) for providing comments on an earlier draft of this article. The project was funded by the NIHR Health Technology Assessment Programme (project number: 17/68/01). The Section of Endocrinology and Investigative Medicine is funded by grants from the MRC and NIHR and is supported by the NIHR Biomedical Research Centre Funding Scheme and the NIHR/Imperial Clinical Research Facility. The views expressed are those of the author(s) and not necessarily those of the NHS, NIHR or Department of Health. Channa N. Jayasena was funded by NIHR post-doctoral fellowship and Waljit S. Dhillo by NIHR Senior Investigator Award.10578229engSDG 3 - Good Health and Well-beingcost-effectivenesseconomic peoplehypogonadismtechnology assessmentTestosteroneR MedicineNational Institute for Health Research (NIHR)17/68/01Medical Research Council (MRC)Supplementary Informationhttps://onlinelibrary.wiley.com/action/downloadSupplement?doi=10.1111%2Fandr.13597&file=andr13597-sup-0001-TablesS1-S3.docxRJournal article10.1111/andr.13597https://www.scopus.com/pages/publications/85182410221